SEC Form 4 · accession 0001179110-17-002000
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Pasqualone
Officer — SVP Global Head Acute Care Bus
Period of report
Feb 6, 2017
Accepted (ET)
Feb 8, 2017 · 7:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 6, 2017 | A | 9,000 | $0.00 | A | 227,880 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2016.